Ekf Diagnostics Regulatory News (EKF)



Regulatory News for Ekf Diagnostics (EKF)


Share Price: 29.50Bid: 28.00Ask: 31.00Change: 0.00 (0.00%)No Movement on Ekf Diagnostics
Spread: 3.00Spread as %: 10.71%Open: 29.50High: 30.75Low: 28.15Yesterday’s Close: 29.50





Holding(s) in Company

Mon, 16th Jul 2012 15:05

RNS Number : 7705H
EKF Diagnostics Holdings PLC
16 July 2012
 

?

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

EKF DIAGNOSTICS HOLDINGS PLC

2. Reason for the notification     (please tick the appropriate box or boxes)


An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify): ___________

                

3. Full name of person(s) subject to the notification obligation:

Ignis Investment Services Limited    

4. Full name of shareholder(s) (if different from 3.):

    

5. Date of the transaction and date on which the threshold is crossed or reached if different:

11/07/2012

6. Date on which issuer notified:

12/07/2012

7. Threshold(s) that is/are crossed or reached:

4%

 

 

8.Notified details: Nominee holdings

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights viii

Number of shares

Number of voting rights

% of voting rights

Direct

Direct 

Indirect

Direct

Indirect

3150980

    


    

    

9,830,731

    

3.87%

 

B: Financial Instruments

 

Resulting situation after the triggering transaction xii

 

Type of financial instrument

Expiration date

Exercise/ Conversion  Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

    

    

 

 

 


 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration Date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights






Nominal

Delta



 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

9,830,731.00

3.87%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Vidacos Nominees Ltd  (9,830,731.00 3.87%)

Phoenix Group Holdings

Impala Holdings Limited

Ignis Asset management Ltd

Ignis Investment Services Ltd (indirect)

 

 

Proxy Voting:

10. Name of the proxy holder:

    

11. Number of voting rights proxy holder will cease to hold:

    

12. Date on which proxy holder will cease to hold voting rights:

    

 

13. Additional information:

Percentage calculation based on Issued Share Capital of 253879110

14. Contact name:

      Jean Birrell

15. Contact telephone number:

     0141 222 8226

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUNRSRUUABAAR






DateSourceHeadlineCategory
15-May-13 16:34RNSResult of AGMResults and Trading Reports
15-May-13 07:00RNSAGM StatementResults and Trading Reports
13-May-13 07:00RNSFirst PointMan DNA enrichment products launchedCompany Announcement - General
15-Apr-13 13:34RNSPublication of Annual Report & Notice of AGMResults and Trading Reports
18-Mar-13 07:00RNSFinal ResultsResults and Trading Reports
04-Mar-13 07:00RNSEstablishment of EKF Molecular & AcquisitionMergers, Acquisitions and Disposals
18-Jan-13 07:00RNSPre-close Trading UpdateResults and Trading Reports
21-Dec-12 15:53RNSDirectors' Exercise of OptionsCompany Announcement - General
17-Dec-12 07:00RNSHolding(s) in CompanyHolding(s) in Company
27-Nov-12 16:32RNSHolding(s) in CompanyHolding(s) in Company
09-Nov-12 07:00RNSIssue of EquityCompany Announcement - General
24-Sep-12 07:00RNSHalf Yearly ReportResults and Trading Reports
05-Sep-12 07:00RNSTrading UpdateCompany Announcement - General
14-Aug-12 07:00RNSNICE guidance on type 2 diabetesCompany Announcement - General
10-Aug-12 07:00RNSHemoCue settlement agreementCompany Announcement - General
17-Jul-12 07:00RNSLicensing agreement for kidney markersCompany Announcement - General
16-Jul-12 15:05RNSHolding(s) in CompanyHolding(s) in Company
16-Jul-12 07:00RNSQuo-Lab CE marking & Commercial launchCompany Announcement - General
12-Jul-12 13:11RNSHolding(s) in CompanyHolding(s) in Company
28-Jun-12 07:00RNSDirector's Share OptionsDirectors' Dealings
26-Jun-12 10:30RNSHolding(s) in CompanyHolding(s) in Company
23-May-12 13:00RNSResult of AGMResults and Trading Reports
11-May-12 07:00RNSUpdate on Disposal of IBL AGMergers, Acquisitions and Disposals
20-Apr-12 11:18RNSPublication of Annual Report & Notice of AGMCompany Announcement - General
18-Apr-12 16:50RNSHolding(s) in CompanyHolding(s) in Company
05-Apr-12 07:00RNSDirectors' Exercise of OptionsDirectors' Dealings
05-Apr-12 07:00RNSChina Patent GrantCompany Announcement - General
03-Apr-12 13:47RNSHolding(s) in CompanyHolding(s) in Company
27-Mar-12 07:00RNSDisposal of International Brand Licensing AGMergers, Acquisitions and Disposals
26-Mar-12 08:18RNSAdviser Change of NameCompany Announcement - General


Regulatory news is displayed end of day, each day at 19:00.
Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.